Author:
Dräger Désirée-Louise,Kunz Benedikt
Publisher
Springer Berlin Heidelberg
Reference34 articles.
1. Ali, A.S., Hayes, M.C., Birch, B., Dudderidge, T., & Somani, B.K. (2015). Health related quality of life (HRQoL) after cystectomy: Comparison between orthotopic neobladder and ileal conduit diversion. European Journal of Surgical Oncology, 41(3), 295–299.
2. Babjuk, M., Böhle, A., Burger, M., Capoun, O., Cohen, D., Compérat, E.M., Hernández, V., Kaasinen, E., Palou, J., Rouprêt, M., van Rhijn, B.W., Shariat, S.F., Soukup, V., Sylvester, R.J., & Zigeuner, R. (2017). EAU Guidelines on non-muscle-invasive urothelial carcinoma of the bladder: Update 2016. European Urology, 71(3), 447–461.
3. Blazeby, J.M., Hall, E., Aaronson, N.K., Lloyd, L., Waters, R., Kelly, J.D., & Fayers, P. (2014). Validation and reliability testing of the EORTC QLQ-NMIBC24 questionnaire module to assess patient-reported outcomes in non-muscle-invasive bladder cancer. European Urology, 66(6), 1148–1156.
4. Cody, J.D., Nabi, G., Dublin, N., McClinton, S., Neal, D.E., Pickard, R., & Yong, S.M. (2012). Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy. Cochrane Database of Systematic Reviews, 2012(2), CD003306.
5. Dräger, D.L., & Schmidt, S. (2017). Pharmacological treatments for fatigue associated with palliative care. Urologe A, 55(8), 1089–1092.